[ca] L'objectiu d'aquesta tesis doctoral es basa en entendre el mecanisme de transport de dos pèptids llançadora de la barrera hematoencefàlica (BHE), el THRre i el MiniAp-4. El treball ha sigut dut a terme a l'Institut de Recerca Biomèdica de Barcelona sota la supervisió de la Dra. Meritxell Teixidó i la Dra. Macarena Sánchez al grup del Prof. Ernest Giralt. La tesis es divideix en dos capítols que corresponen als dos pèptids estudiats. En el primer capítol estudiem en detall el THRre. Aquest pèptid va ser descobert pel Dr. Roger Prades al nostre laboratori i es basa en la versió retroenantio del THR. Els dos pèptids creuen la BHE amb el receptor de transferrina. El primer objectiu va ser demostrar aquesta interacció a traves d'una tècnica de ressonància magnètica nuclear (RMN) anomenada saturated transfer difference (STD). Es va poder demostrat aquesta interacció i predir que la part de la seqüencia on hi ha els triptòfans és més responsable d'aquesta interacció. Llavors es va voler obtenir una costant de dissociació (KD) mitjançant dues tècniques biofísiques: calorimetria i SAW (sensor acoustic wavelenght). Només es vam obtenir una valor de KD per el THR, mentre que pel THRre no va ser possible, suggerint que la interacció és feble. Mitjançant estudis de photocrosslinking es va voler estudiar el lloc d'unió al receptor. El segon capítol es basa en el MiniAp-4, el qual prové de l'apamina present al verí d'abella. És una versió cíclica no tòxica la qual ha demostrat la seva capacitat de creuar diferents compostos in vitro i in vivo. Les bones propietats d'aquest pèptid llançadora van ser atribuïdes a la seva alta estabilitat contra proteases i l'excepcional proporció 1:1 cis/trans de la prolina. El primer objectiu va ser sintetitzar diferents anàlegs i veure si hi havia una relació entre la proporció cis/trans i el transport a través d'un model humà de BHE. Tot i que els resultats van demostrar que no hi havia una relació directe entre la conformació de la prolina i el transport, un dels anàlegs va mostrar una major capacitat de transport un fluòfor com la carboxifluoresceïna. Un altre objectiu va ser estudiar el mecanisme de transport d'aquest pèptid mitjançant diferents estudis de microscòpia que van suggerir que el pèptid utilitza una via depenent i no dependent de clatrina, i que un cop es dins la cèl·lula va a una via de degradació. També es van realitzar estudis de photocrosslinking mitjançant un anàleg fotoreactiu per poder saber amb quines proteïnes interacciona durant la internalització.

[en] The research work presented in this thesis aims to understand the transport mechanism of two described BBB-shuttles, THRre and MiniAp-4. To achieve these objectives, different techniques have been used as solid phase peptide synthesis (SPPS), blood-brain barrier (BBB) cellular models, biophysical techniques, nuclear magnetic resonance (NMR), photocrosslinking techniques and microscopy. The work was performed at the Institute for Research in Biomedicine (IRB) supervised by Dr. Meritxell Teixidó and Dr. Macarena Sánchez in the group of Prof. Ernest Giralt. The introduction presents an overview of the main topics discussed in this thesis, how the presence of the BBB difficult the pass of most of potential therapeutics and the need to find tools to overcome this problem. Also, a thorough introduction on the main transport mechanism across the barrier is given. The thesis is divided in two chapters. The first one consists of THRre peptide. This peptide was developed by Dr. Roger Prades and corresponds to the retroenantio version of THR, which was discovered by phage display. This two peptides present a capacity to transport a wide variety of cargoes in vitro and in vivo. It was already known that they use the transferrin receptor (TfR) to cross the BBB. Our first objective was to prove it by a saturated transfer difference (STD) NMR experiment. We were able to confirm the interaction between the two peptides and by measuring the STD effect, we could hypothesize the part of the sequence which is responsible for the interaction. Then, we tried to characterize this interaction by measuring the constant of dissociation (KD) by isothermal titration calorimetry (ITC) and sensor acoustic wavelength (SAW). A KD value around 1 mM was obtained for THR, however it was not possible to measure it for THRre, suggesting that the interaction is weak. We also wanted to elucidate the binding site of THR and THRre to the receptor by photocrosslinking. To this end, two photoreactive version were synthesised for each peptide, substituting one of the tryptophan for a non-natural commercial amino acid bearing a benzophenone moiety, a 4-benzoylphenylalanine (Bpa). The second chapter is based on MiniAp-4, a short non-toxic cyclic version of apamin venom developed by Dr. Benjamí Oller in our group. The good transport properties of this peptides were attributed at its high stability against proteases and its remarkable 1:1 cis/trans proline conformation. The first objective was to synthesize seven different analogues changing the length of the cycle and swapping the proline for a dimethylproline residue in order to see if differences in the cis/trans ratio lead to differences in transport capacity. After, by NMR techniques cis/trans ratios were measured and peptides were assessed in a human BBB model, however no significant differences were observed between analogues. In addition, the candidate that presented an 85% cis conformation showed better transport capacity for a small cargo. The second objective was to study the uptake of MiniAp-4 in brain endothelial cell line using quantum dots (QDs) nanoparticles. Nevertheless, we could conclude that even though the peptide was able to carry QDs inside the cell, these type of nanoparticles were not the ideal ones. Finally, we aimed to understand the transport mechanism of this peptide by confocal microscopy and photocrosslinking. A conjugated cyanine_MiniAp-4 was co-incubated with transferrin and cholera toxin, which are described to internalize via clathrin dependent and clathrin independent mechanism respectively. A co-localization with both controls was observed however, we suggest that the main route of entry is through caveolae. Also, different antibody staining performed in order to understand the route that MiniAp-4 takes once inside the cell suggested that maybe a degradation pathway is followed. For the photocrosslinking experiments, we developed a photo-crosslinking strategy in which we designed and synthesized a biotinylated photo-reactive analogue that contains a photo-proline and a cleavable linker. After evaluation by top down mass spectrometry, we obtained different potential membrane proteins, however further experiments need to be done in order to confirm it.